Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.
2024/3/29 7:36:29
(ESPR:NASDAQ)
Streetwise Reports Articles